Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, drugstore and pharmacy benefits giant CVS Caremark (NYSE: CVS) has earned a respected four-star ranking.

With that in mind, let's take a closer look at CVS' business and see what CAPS investors are saying about the stock right now.

CVS facts

Headquarters (Founded) Woonsocket, R.I. (1892)
Market Cap $46.56 billion
Industry Drug retail
Trailing-12-Month Revenue $96.41 billion
Management CEO Larry Merlo (since March 2011)
CFO David Denton (since January 2010)
Return on Equity (Average, Past 3 Years) 10%
Cash / Debt $1.43 billion / $10.06 billion
Dividend Yield 1.5%
Competitors MedcoHealth Solutions (NYSE: MHS)
Walgreen (NYSE: WAG)
Wal-Mart (NYSE: WMT)

Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.

On CAPS, 96% of the 1,660 members who have rated CVS believe the stock will outperform the S&P 500 going forward. These bulls include JohnGalt21 and jpsheb.

Late last month, JohnGalt21 touched on the huge demographic trend working in CVS' favor: "Sales of prescription drugs will rise as baby boomers continue to retire and the federal government continues unfettered in its willingness to help subsidize them."

Over the past five years, CVS has even grown its bottom line at a solid rate of 22.9% annually. That's faster than competitors Walgreen (6.7%), Wal-Mart (7.9%), and MedcoHealth (18.8%).

CAPS member jpsheb expands on CVS' ubiquitous nature:

It is a prominent drug chain with plenty of room to grow. In many communities I have seen, it, like [Walgreen], is a neighborhood drug store selling both retail products and offering Pharmacy services. The demand of its products, medical consumer products and generic drugs, should continue to increase with a "boom" in retirement and aging of the population beginning now and continuing over the next 15-20 years.

What do you think about CVS, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. MedcoHealth is a Motley Fool Stock Advisor selection. Wal-Mart is a Motley Fool Inside Value and Global Gains pick. Motley Fool Options has recommended a diagonal call position on Wal-Mart, and the Fool owns shares of it. Try any of our Foolish newsletter services free for 30 days.

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.